CMA to appeal hydrocortisone ruling
The CMA believes the CAT’s decision to overturn nearly £100 million of fines for drug firms despite initially confirming flagrant anti-competitive conduct is fundamentally misconceived. The CMA has a duty to ensure effective… read more